Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 138

1.

Contrapositive logic suggests space radiation not having a strong impact on mortality of US astronauts and Soviet and Russian cosmonauts.

Reynolds RJ, Bukhtiyarov IV, Tikhonova GI, Day SM, Ushakov IB, Gorchakova TYU.

Sci Rep. 2019 Jul 4;9(1):8583. doi: 10.1038/s41598-019-44858-0.

2.

Mortality Among International Astronauts.

Reynolds RJ, Day SM.

Aerosp Med Hum Perform. 2019 Jul 1;90(7):647-651. doi: 10.3357/AMHP.5369.2019.

PMID:
31227040
3.

Establishment of Specialized Clinical Cardiovascular Genetics Programs: Recognizing the Need and Meeting Standards: A Scientific Statement From the American Heart Association.

Ahmad F, McNally EM, Ackerman MJ, Baty LC, Day SM, Kullo IJ, Madueme PC, Maron MS, Martinez MW, Salberg L, Taylor MR, Wilcox JE.

Circ Genom Precis Med. 2019 Jun;12(6):e000054. doi: 10.1161/HCG.0000000000000054. Epub 2019 May 23.

PMID:
31117808
4.

Glucagon-Like Peptide-1 Cleavage Product Improves Cognitive Function in a Mouse Model of Down Syndrome.

Day SM, Yang W, Wang X, Stern JE, Zhou X, Macauley SL, Ma T.

eNeuro. 2019 May 15;6(2). pii: ENEURO.0031-19.2019. doi: 10.1523/ENEURO.0031-19.2019. Print 2019 Mar/Apr.

5.

Response by Ho et al to Letter Regarding Article, "Genotype and Lifetime Burden of Disease in Hypertrophic Cardiomyopathy: Insights From the Sarcomeric Human Cardiomyopathy Registry (SHaRe)".

Ho CY, Day SM, Ashley EA, Michels M, Pereira AC, Jacoby D, Lakdawala NK, Ware JS, Helms AS, Colan SD, Seidman CE, Olivotto I; SHaRe Investigators.

Circulation. 2019 Mar 19;139(12):1559-1560. doi: 10.1161/CIRCULATIONAHA.118.039069. No abstract available.

PMID:
30883221
6.

Therapeutic Potential of Glucagon-Like Peptide-1 Cleavage Product for Alzheimer's Disease.

Day SM, Ma T.

Neurosci Bull. 2019 Mar 7. doi: 10.1007/s12264-019-00355-y. [Epub ahead of print] No abstract available.

PMID:
30843143
7.

17-╬▒ estradiol ameliorates age-associated sarcopenia and improves late-life physical function in male mice but not in females or castrated males.

Garratt M, Leander D, Pifer K, Bower B, Herrera JJ, Day SM, Fiehn O, Brooks SV, Miller RA.

Aging Cell. 2019 Apr;18(2):e12920. doi: 10.1111/acel.12920. Epub 2019 Feb 10.

8.

Nonobstructive Hypertrophic Cardiomyopathy-The High-Hanging Fruit.

Day SM.

JAMA Cardiol. 2019 Mar 1;4(3):235-236. doi: 10.1001/jamacardio.2018.4953. No abstract available.

PMID:
30725087
9.

Quantitative approaches to variant classification increase the yield and precision of genetic testing in Mendelian diseases: the case of hypertrophic cardiomyopathy.

Walsh R, Mazzarotto F, Whiffin N, Buchan R, Midwinter W, Wilk A, Li N, Felkin L, Ingold N, Govind R, Ahmad M, Mazaika E, Allouba M, Zhang X, de Marvao A, Day SM, Ashley E, Colan SD, Michels M, Pereira AC, Jacoby D, Ho CY, Thomson KL, Watkins H, Barton PJR, Olivotto I, Cook SA, Ware JS.

Genome Med. 2019 Jan 29;11(1):5. doi: 10.1186/s13073-019-0616-z.

10.

Mortality Rates and Excess Death Rates for the Seriously Mentally Ill.

Reynolds RJ, Day SM, Shafer A, Becker E.

J Insur Med. 2018;47(4):212-219. doi: 10.17849/insm-47-04-1-8.1. Epub 2019 Jan 17.

PMID:
30653378
11.

Left Ventricular Strain Is Abnormal in Preclinical and Overt Hypertrophic Cardiomyopathy: Cardiac MR Feature Tracking.

Vigneault DM, Yang E, Jensen PJ, Tee MW, Farhad H, Chu L, Noble JA, Day SM, Colan SD, Russell MW, Towbin J, Sherrid MV, Canter CE, Shi L, Ho CY, Bluemke DA.

Radiology. 2019 Mar;290(3):640-648. doi: 10.1148/radiol.2018180339. Epub 2018 Dec 18.

PMID:
30561279
12.

MYBPC3 truncation mutations enhance actomyosin contractile mechanics in human hypertrophic cardiomyopathy.

O'Leary TS, Snyder J, Sadayappan S, Day SM, Previs MJ.

J Mol Cell Cardiol. 2019 Feb;127:165-173. doi: 10.1016/j.yjmcc.2018.12.003. Epub 2018 Dec 11.

PMID:
30550750
13.

Mortality of US astronauts: comparisons with professional athletes.

Reynolds RJ, Day SM.

Occup Environ Med. 2019 Feb;76(2):114-117. doi: 10.1136/oemed-2018-105304. Epub 2018 Dec 4.

PMID:
30514748
14.

The crisis in replicability.

Rigby AS, Day SM.

Dev Med Child Neurol. 2019 May;61(5):504. doi: 10.1111/dmcn.14105. Epub 2018 Nov 25. No abstract available.

PMID:
30474136
15.

Allelic imbalance and haploinsufficiency in MYBPC3-linked hypertrophic cardiomyopathy.

Glazier AA, Thompson A, Day SM.

Pflugers Arch. 2019 May;471(5):781-793. doi: 10.1007/s00424-018-2226-9. Epub 2018 Nov 20. Review.

PMID:
30456444
16.

Incident Atrial Fibrillation Is Associated With MYH7 Sarcomeric Gene Variation in Hypertrophic Cardiomyopathy.

Lee SP, Ashley EA, Homburger J, Caleshu C, Green EM, Jacoby D, Colan SD, Arteaga-Fernández E, Day SM, Girolami F, Olivotto I, Michels M, Ho CY, Perez MV; SHaRe Investigators.

Circ Heart Fail. 2018 Sep;11(9):e005191. doi: 10.1161/CIRCHEARTFAILURE.118.005191.

PMID:
30354366
17.

Genotype and Lifetime Burden of Disease in Hypertrophic Cardiomyopathy: Insights from the Sarcomeric Human Cardiomyopathy Registry (SHaRe).

Ho CY, Day SM, Ashley EA, Michels M, Pereira AC, Jacoby D, Cirino AL, Fox JC, Lakdawala NK, Ware JS, Caleshu CA, Helms AS, Colan SD, Girolami F, Cecchi F, Seidman CE, Sajeev G, Signorovitch J, Green EM, Olivotto I.

Circulation. 2018 Oct 2;138(14):1387-1398. doi: 10.1161/CIRCULATIONAHA.117.033200. Epub 2018 Aug 23.

18.

The effect of competing risks on astronaut and cosmonaut mortality.

Reynolds RJ, Day SM.

Life Sci Space Res (Amst). 2018 Aug;18:35-41. doi: 10.1016/j.lssr.2018.05.006. Epub 2018 May 23.

PMID:
30100146
19.

Exercise hemodynamics in hypertrophic cardiomyopathy identify risk of incident heart failure but not ventricular arrhythmias or sudden cardiac death.

Smith ED, Tome J, Mcgrath R, Kumar S, Concannon M, Day SM, Saberi S, Helms AS.

Int J Cardiol. 2019 Jan 1;274:226-231. doi: 10.1016/j.ijcard.2018.07.110. Epub 2018 Jul 24.

PMID:
30075967
20.

Response by Saberi and Day to Letter Regarding Article, "Exercise and Hypertrophic Cardiomyopathy: Time for a Change of Heart".

Saberi S, Day SM.

Circulation. 2018 Jul 17;138(3):333-334. doi: 10.1161/CIRCULATIONAHA.118.035305. No abstract available.

21.

HSC70 is a chaperone for wild-type and mutant cardiac myosin binding protein C.

Glazier AA, Hafeez N, Mellacheruvu D, Basrur V, Nesvizhskii AI, Lee LM, Shao H, Tang V, Yob JM, Gestwicki JE, Helms AS, Day SM.

JCI Insight. 2018 Jun 7;3(11). pii: 99319. doi: 10.1172/jci.insight.99319. eCollection 2018 Jun 7.

22.

Whole-Exome Sequencing Reveals GATA4 and PTEN Mutations as a Potential Digenic Cause of Left Ventricular Noncompaction.

Tang VT, Arscott P, Helms AS, Day SM.

Circ Genom Precis Med. 2018 Jan;11(1):e001966. doi: 10.1161/CIRCGEN.117.001966. No abstract available.

PMID:
29874181
23.

The growing role of machine learning and artificial intelligence in developmental medicine.

Reynolds RJ, Day SM.

Dev Med Child Neurol. 2018 Sep;60(9):858-859. doi: 10.1111/dmcn.13917. Epub 2018 May 13. No abstract available.

PMID:
29756203
24.

Prevalence and Progression of Late Gadolinium Enhancement in Children and Adolescents With Hypertrophic Cardiomyopathy.

Axelsson Raja A, Farhad H, Valente AM, Couce JP, Jefferies JL, Bundgaard H, Zahka K, Lever H, Murphy AM, Ashley E, Day SM, Sherrid MV, Shi L, Bluemke DA, Canter CE, Colan SD, Ho CY.

Circulation. 2018 Aug 21;138(8):782-792. doi: 10.1161/CIRCULATIONAHA.117.032966.

PMID:
29622585
25.

Erratum to "Vigorous exercise in hypertrophic cardiomyopathy: Benefits may outweigh the risks" [Int. J. Cardiol. 250 (2018) 229-230].

Saberi S, Day SM.

Int J Cardiol. 2018 Jun 15;261:242. doi: 10.1016/j.ijcard.2018.02.104. Epub 2018 Mar 9. No abstract available.

PMID:
29526490
26.

On the Road from Gene to Therapy in Inherited Cardiomyopathies.

Limongelli G, Bossone E, Elliott PM, Day SM.

Heart Fail Clin. 2018 Apr;14(2):xi-xv. doi: 10.1016/j.hfc.2018.01.003. No abstract available.

PMID:
29525651
27.

Epidemiology and Clinical Aspects of Genetic Cardiomyopathies.

Masarone D, Kaski JP, Pacileo G, Elliott PM, Bossone E, Day SM, Limongelli G.

Heart Fail Clin. 2018 Apr;14(2):119-128. doi: 10.1016/j.hfc.2017.12.007. Review.

PMID:
29525641
28.

Exercise and Hypertrophic Cardiomyopathy: Time for a Change of Heart.

Saberi S, Day SM.

Circulation. 2018 Jan 30;137(5):419-421. doi: 10.1161/CIRCULATIONAHA.117.029989. No abstract available.

PMID:
29378753
29.

Left Atrial structure and function in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy.

Farhad H, Seidelmann SB, Vigneault D, Abbasi SA, Yang E, Day SM, Colan SD, Russell MW, Towbin J, Sherrid MV, Canter CE, Shi L, Jerosch-Herold M, Bluemke DA, Ho C, Neilan TG.

J Cardiovasc Magn Reson. 2017 Dec 28;19(1):107. doi: 10.1186/s12968-017-0420-0.

30.

Biomarkers of cardiovascular stress and fibrosis in preclinical hypertrophic cardiomyopathy.

Ho JE, Shi L, Day SM, Colan SD, Russell MW, Towbin JA, Sherrid MV, Canter CE, Jefferies JL, Murphy A, Taylor M, Mestroni L, Cirino AL, Sleeper LA, Jarolim P, Lopez B, Gonzalez A, Diez J, Orav EJ, Ho CY.

Open Heart. 2017 Nov 1;4(2):e000615. doi: 10.1136/openhrt-2017-000615. eCollection 2017.

31.

Vigorous exercise in hypertrophic cardiomyopathy: Benefits may outweigh the risks.

Saberi S, Day SM.

Int J Cardiol. 2018 Jan 1;250:229-230. doi: 10.1016/j.ijcard.2017.09.205. No abstract available. Erratum in: Int J Cardiol. 2018 Mar 8;:.

PMID:
29169755
32.

Diagnosis in the age of massive computing power.

Day SM, Reynolds RJ.

Dev Med Child Neurol. 2017 Dec;59(12):1211-1212. doi: 10.1111/dmcn.13593. Epub 2017 Oct 16. No abstract available.

33.

Care in Specialized Centers and Data Sharing Increase Agreement in Hypertrophic Cardiomyopathy Genetic Test Interpretation.

Furqan A, Arscott P, Girolami F, Cirino AL, Michels M, Day SM, Olivotto I, Ho CY, Ashley E, Green EM, Caleshu C; SHaRe Consortium.

Circ Cardiovasc Genet. 2017 Oct;10(5). pii: e001700. doi: 10.1161/CIRCGENETICS.116.001700.

PMID:
28986452
34.
35.

Founder Mutations in Myosin-Binding Protein C: Maybe Not So Benign After All.

Thompson AD, Day SM.

Circ Cardiovasc Genet. 2017 Aug;10(4). pii: e001872. doi: 10.1161/CIRCGENETICS.117.001872. No abstract available.

PMID:
28794114
36.

Role of Genetic Testing in Inherited Cardiovascular Disease: A Review.

Cirino AL, Harris S, Lakdawala NK, Michels M, Olivotto I, Day SM, Abrams DJ, Charron P, Caleshu C, Semsarian C, Ingles J, Rakowski H, Judge DP, Ho CY.

JAMA Cardiol. 2017 Oct 1;2(10):1153-1160. doi: 10.1001/jamacardio.2017.2352. Review.

PMID:
28793145
37.

Exercise for Patients With Hypertrophic Cardiomyopathy-Reply.

Saberi S, Wheeler M, Day SM.

JAMA. 2017 Aug 1;318(5):481-482. doi: 10.1001/jama.2017.8201. No abstract available.

PMID:
28763545
38.

Growth charts for cerebral palsy: still imperfect, but gaining in value.

Day SM.

Dev Med Child Neurol. 2017 Sep;59(9):887. doi: 10.1111/dmcn.13522. Epub 2017 Jul 27. No abstract available.

39.

Genetic testing impacts the utility of prospective familial screening in hypertrophic cardiomyopathy through identification of a nonfamilial subgroup.

Ko C, Arscott P, Concannon M, Saberi S, Day SM, Yashar BM, Helms AS.

Genet Med. 2018 Jan;20(1):69-75. doi: 10.1038/gim.2017.79. Epub 2017 Jun 22.

PMID:
28640247
40.

The Design of the Valsartan for Attenuating Disease Evolution in Early Sarcomeric Hypertrophic Cardiomyopathy (VANISH) Trial.

Ho CY, McMurray JJV, Cirino AL, Colan SD, Day SM, Desai AS, Lipshultz SE, MacRae CA, Shi L, Solomon SD, Orav EJ, Braunwald E; VANISH trial investigators and executive committee.

Am Heart J. 2017 May;187:145-155. doi: 10.1016/j.ahj.2017.02.008. Epub 2017 Feb 16.

41.

Mortality Due to Cardiovascular Disease Among Apollo Lunar Astronauts.

Reynolds RJ, Day SM.

Aerosp Med Hum Perform. 2017 May 1;88(5):492-496. doi: 10.3357/AMHP.4757.2017. Erratum in: Aerosp Med Hum Perform. 2017 Nov 1;88(11):1055.

PMID:
28417839
42.

Effect of Moderate-Intensity Exercise Training on Peak Oxygen Consumption in Patients With Hypertrophic Cardiomyopathy: A Randomized Clinical Trial.

Saberi S, Wheeler M, Bragg-Gresham J, Hornsby W, Agarwal PP, Attili A, Concannon M, Dries AM, Shmargad Y, Salisbury H, Kumar S, Herrera JJ, Myers J, Helms AS, Ashley EA, Day SM.

JAMA. 2017 Apr 4;317(13):1349-1357. doi: 10.1001/jama.2017.2503. Erratum in: JAMA. 2017 May 23;317(20):2134.

43.

The Burden of Early Phenotypes and the Influence of Wall Thickness in Hypertrophic Cardiomyopathy Mutation Carriers: Findings From the HCMNet Study.

Ho CY, Day SM, Colan SD, Russell MW, Towbin JA, Sherrid MV, Canter CE, Jefferies JL, Murphy AM, Cirino AL, Abraham TP, Taylor M, Mestroni L, Bluemke DA, Jarolim P, Shi L, Sleeper LA, Seidman CE, Orav EJ; HCMNet Investigators.

JAMA Cardiol. 2017 Apr 1;2(4):419-428. doi: 10.1001/jamacardio.2016.5670.

44.

Other side of the coin: the missing heritability in hypertrophic cardiomyopathy.

Helms AS, Day SM.

Eur Heart J. 2017 Dec 7;38(46):3469-3471. doi: 10.1093/eurheartj/ehx024. No abstract available.

PMID:
28201496
45.

The evolutionary origination of a novel expression pattern through an extreme heterochronic shift.

Pham T, Day SM, Glassford WJ, Williams TM, Rebeiz M.

Evol Dev. 2017 Mar;19(2):43-55. doi: 10.1111/ede.12215. Epub 2017 Jan 24.

PMID:
28116844
46.

Exercise Prescription for the Athlete with Cardiomyopathy.

Saberi S, Day SM.

Cardiol Clin. 2016 Nov;34(4):591-601. doi: 10.1016/j.ccl.2016.06.008. Epub 2016 Aug 28. Review.

PMID:
27692227
47.

Genotype-Dependent and -Independent Calcium Signaling Dysregulation in Human Hypertrophic Cardiomyopathy.

Helms AS, Alvarado FJ, Yob J, Tang VT, Pagani F, Russell MW, Valdivia HH, Day SM.

Circulation. 2016 Nov 29;134(22):1738-1748. Epub 2016 Sep 29.

48.

Deficient cMyBP-C protein expression during cardiomyocyte differentiation underlies human hypertrophic cardiomyopathy cellular phenotypes in disease specific human ES cell derived cardiomyocytes.

Monteiro da Rocha A, Guerrero-Serna G, Helms A, Luzod C, Mironov S, Russell M, Jalife J, Day SM, Smith GD, Herron TJ.

J Mol Cell Cardiol. 2016 Oct;99:197-206. doi: 10.1016/j.yjmcc.2016.09.004. Epub 2016 Sep 10.

49.

Interferon-dependent immunoproteasome activity during mouse adenovirus type 1 infection.

McCarthy MK, Malitz DH, Molloy CT, Procario MC, Greiner KE, Zhang L, Wang P, Day SM, Powell SR, Weinberg JB.

Virology. 2016 Nov;498:57-68. doi: 10.1016/j.virol.2016.08.009. Epub 2016 Aug 22.

50.

Complement Destabilizes Cardiomyocyte Function In Vivo after Polymicrobial Sepsis and In Vitro.

Kalbitz M, Fattahi F, Herron TJ, Grailer JJ, Jajou L, Lu H, Huber-Lang M, Zetoune FS, Sarma JV, Day SM, Russell MW, Jalife J, Ward PA.

J Immunol. 2016 Sep 15;197(6):2353-61. doi: 10.4049/jimmunol.1600091. Epub 2016 Aug 12.

Supplemental Content

Support Center